JDP Therapeutics Inc. is a privately held, specialty pharmaceutical company focused on developing and commercializing proprietary product candidates for the treatment of life threatening diseases with significant unmet medical needs, principally for use in the hospital and urgent care settings.
JDP Secures $17 Million in Series A Financing
June 28, 2016
JDP Enters Development and Supply Agreement with Hospira/Pfizer
March 24, 2016
JDP Announces Notice of Allowance for Two New Patents Covering JDP-205 and JDP-207.
July 20, 2015